Personal information

Angioedema, Bleeding, Factor XII, Fibrinolysis, Plasmin, TTP, Thrombosis, von Willebrand Factor, Contact System, Bradykinin
Netherlands

Biography

Lives and works in Utrecht, the Netherlands. Likes to study and manipulate blood enzymes in the context of severe and poorly understood diseases, for deeper insight into mechanisms that drive large health threats.

Associate professor Thrombosis and Hemostasis, @ UMC Utrecht
Adjunct professor Immunothrombosis, @ University of South Denmark
Chair SSC Factor XI and the Contact System @ ISTH
CSO of TargED Biopharmaceuticals

Patents.
P6064890EP Modified serpins for the treatment of bradykinin-mediated disease
P6074456EP Treatment of Microvascular Thrombosis

Grants/Prizes:
2020 ZonMW Top-down Dutch COVID and Thrombosis Coalition (€ 800k; € 250k for responsible work package).
2020 Health Holland TKI-PPS Allowance (€ 870k)
2020 Thrombosis Foundation Holland (Trombosestichting) (€ 250k)
2020 UMC Utrecht – KU Leuven collaboration grant (€ 50k)
2019 CVON CONTRAST Voucher (€ 50k)
2019 NWO Technische en Toegepaste Wetenschappen (TTW) Take-off grant (€ 40k)
2019 ISTH SSC Grant COSYNE (50k USD)
2018 Dutch Life Sciences Investors Forum 1st Prize (2500 Euro)
2018 E.K. Frey – E. Werle Foundation of the Henning L. Voigt Family - Young Investigator Award
2014 Eberhard F Mammen Young Investigator Award ($ 1000)
Thieme Medical Publishers: Seminars in Thrombosis and Hemostasis
2011 Young Investigator Award ($ 500) International Society on Thrombosis and Haemostasis O-TU 099
2011 Young Investigator Award ($ 500 ) International Society on Thrombosis and Haemostasis O-TH 055
2010 Karolinska Institutets Forskingsstiftelser (Res. Grant) (26.200 SEK / € 3000,-) Karolinska University Hospital
2009 Young Investigator Award ($ 500) International Society on Thrombosis and Haemostasis
2009 Award for Scientific Excellence in Biochemical Research (1st Prize; € 2000,-) Dutch Association for Thrombosis and Haemostasis (NVTH)
2009 Best Publication Prize (€ 500,-) Utrecht University Graduate School of Biomembranes
2008 PhD Student Award for Scientific Excellence (€ 750,-) Utrecht University Medical Center

Activities

Employment (7)

University Medical Center Utrecht: Utrecht, Utrecht, NL

2018-01-01 to present | Associate professor (Clinical Chemistry and Haematology)
Employment
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2015-01-01 to present | Assistant professor (Department of Clinical Chemistry and Haematology)
Employment
Source: Self-asserted source
Coen Maas

Karolinska Institutet: Stockholm, SE

2010-02-02 to present | Postdoc (Center for Molecular Medicine)
Employment
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2011-02-02 to 2015-01-01 | Postdoc (Department of Clinical Chemistry and Haematology)
Employment
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2009-01-01 to 2010-02-02 | Postdoc (Department of Clinical Chemistry and Haematology)
Employment
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2005-01-01 to 2008-12-31 | Ph.D candidate (Department of Clinical Chemistry and Haematology)
Employment
Source: Self-asserted source
Coen Maas

Bioceros BV: Utrecht, Utrecht, NL

2004-09-01 to 2005-01-01 | Junior Researcher
Employment
Source: Self-asserted source
Coen Maas

Education and qualifications (5)

Universiteit Utrecht Faculteit Geneeskunde: Utrecht, Utrecht, NL

2017-01-01 to present | Academic Teaching (BKO) (Clinical Chemistry and Haematology)
Qualification
Source: Self-asserted source
Coen Maas

Universiteit Utrecht Faculteit Geneeskunde: Utrecht, Utrecht, NL

2004-01-01 to present | FELASA C (Clinical Chemistry and Haematology)
Qualification
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2005-01-01 to 2008-12-16 | Ph.D candidate
Education
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

2002-09-01 to 2004-09-01 | MSc Science and Business Management
Education
Source: Self-asserted source
Coen Maas

Universitair Medisch Centrum Utrecht: Utrecht, Utrecht, NL

1999-09-01 to 2002-09-01 | BSc
Education
Source: Self-asserted source
Coen Maas

Professional activities (4)

International Society on Thrombosis and Haemostasis Inc: Carrboro, NC, US

2019-08-01 to present | Chair SSC Factor XI and the Contact System
Invited position
Source: Self-asserted source
Coen Maas

Seminars in Thrombosis and Haemostasis: Utrecht, NL

2019-01-01 to present | Editorial Board Member
Invited position
Source: Self-asserted source
Coen Maas

Journal of Thrombosis and Haemostasis: Utrecht, NL

2017 to present | Editorial Board Member
Invited position
Source: Self-asserted source
Coen Maas

International Society on Thrombosis and Haemostasis Inc: Carrboro, NC, US

2010 to present
Membership
Source: Self-asserted source
Coen Maas

Funding (8)

Microlyse

2019-07 to 2020-03 | Grant
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Utrecht, NL)
Source: Self-asserted source
Coen Maas

Designer SERPINs

2017-09 to 2018-03 | Grant
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Utrecht, NL)
Source: Self-asserted source
Coen Maas

Nature's nanoparticles

2017-08 to 2021-04 | Grant
Trombosestichting Nederland (Voorschoten, NL)
Source: Self-asserted source
Coen Maas

One cut too many

2014-09 to 2016-09 | Grant
HAEi (Unknown, US)
Source: Self-asserted source
Coen Maas

A Dangerous Enzyme Revealed

2012-01 to 2015-01 | Grant
Netherlands Organization for Scientific Research (The Hague, NL)
GRANT_NUMBER: 91612159
Source: Self-asserted source
Coen Maas

Chimerate

2012 to 2014 | Award
Bayer Healthcare (Berlin, DE)
Source: Self-asserted source
Coen Maas

Plasma Kallikrein in Thrombotic Disease

2011-02 to 2012-02 | Grant
Netherlands Organization for Scientific Research (The Hague, NL)
Source: Self-asserted source
Coen Maas

Plasmin to the rescue

2015-11 | Grant
Landsteiner Foundation for Blood Transfusion Research (Amsterdam, NL)
Source: Self-asserted source
Coen Maas

Works (50 of 123)

Items per page:
Page 1 of 3

Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody

Journal of Thrombosis and Haemostasis
2024-09 | Journal article
Contributors: Rowan Frunt; Hinde El Otmani; Simone Smits; Chantal C. Clark; Coen Maas
Source: check_circle
Crossref

Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity

International Journal of Molecular Sciences
2023-04-12 | Journal article
Contributors: Jens Van Bael; Aline Vandenbulcke; Abdelhakim Ahmed-Belkacem; Jean-François Guichou; Jean-Michel Pawlotsky; Jelle Samyn; Arjan D. Barendrecht; Coen Maas; Simon F. De Meyer; Karen Vanhoorelbeke et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models

Blood
2022-12-29 | Journal article
Contributors: Marc V. A. van Moorsel; Steven de Maat; Kristof Vercruysse; Esther M. van Leeuwen; Charlène Jacqmarcq; Thomas Bonnard; Denis Vivien; H. Bart van der Worp; Rick M. Dijkhuizen; Coen Maas
Source: check_circle
Crossref

Erratum: Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury

American journal of respiratory and critical care medicine
2022-11 | Journal article
Contributors: Wygrecka M; Wujak L; Markart P; Kosanovic D; Müller-Redetzky H; Witzenrath M; Henneke I; Schermuly R; Seeger W; Schaefer L et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Factor XII explored with AlphaFold - opportunities for selective drug development.

Thrombosis and haemostasis
2022-09 | Journal article
Contributors: Frunt R; El Otmani H; Kaira BG; de Maat S; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: A retrospective cohort study.

Research and practice in thrombosis and haemostasis
2022-08 | Journal article
Contributors: Noordermeer T; Schutgens REG; Visser C; Rademaker E; de Maat MPM; Jansen AJG; Limper M; Cremer OL; Kruip MJHA; Endeman H et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α<sub>1</sub>-antitrypsin-derived peptide motif.

Nature nanotechnology
2022-07 | Journal article
Contributors: Cruz MA; Bohinc D; Andraska EA; Alvikas J; Raghunathan S; Masters NA; van Kleef ND; Bane KL; Hart K; Medrow K et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema.

Allergy
2022-07 | Journal article
Contributors: Alizadeh Aghdam M; Hofman ZLM; Meertens M; Lebens A; Hack CE; Knulst AC; Maas C; Röckmann H
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis

Journal of Thrombosis and Haemostasis
2022-06 | Journal article
Contributors: Judith J. de Vries; Chantal Visser; Lotte Geers; Johan A. Slotman; Nadine D. van Kleef; Coen Maas; Hannelore I. Bax; Jelle R. Miedema; Eric C.M. van Gorp; Marco Goeijenbier et al.
Source: check_circle
Crossref

Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach

Journal of Thrombosis and Haemostasis
2022-05 | Journal article
Contributors: Emma Rademaker; Dennis J. Doorduijn; Nuray Kusadasi; Coen Maas; Julia Drylewicz; Albert Huisman; Imo E. Hoefer; Marc J.M. Bonten; Lennie P.G. Derde; Suzan H.M. Rooijakkers et al.
Source: check_circle
Crossref

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

Journal of Thrombosis and Haemostasis
2022-05 | Journal article
Contributors: Marc V.A. van Moorsel; Geke C. Poolen; Cornelis A. Koekman; Sandra Verhoef; Steven de Maat; Arjan Barendrecht; Nadine D. van Kleef; Joost C.M. Meijers; Raymond M. Schiffelers; Coen Maas et al.
Source: check_circle
Crossref

Disturbed lipid and amino acid metabolisms in COVID-19 patients.

Journal of molecular medicine (Berlin, Germany)
2022-01 | Journal article
Contributors: Masoodi M; Peschka M; Schmiedel S; Haddad M; Frye M; Maas C; Lohse A; Huber S; Kirchhof P; Nofer JR et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Serum proteases prevent bacterial biofilm formation: role of kallikrein and plasmin.

Virulence
2021-12 | Journal article
Contributors: Arenas J; Szabo Z; van der Wal J; Maas C; Riaz T; Tønjum T; Tommassen J
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Microlyse; a thrombolytic agent that targets VWF for clearance of microvascular thrombosis.

Blood
2021-11 | Journal article
Contributors: de Maat S; Clark C; Barendrecht AD; Smits S; van Kleef ND; El Otmani H; Waning M; van Moorsel MVA; Szardenings M; Delaroque N et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

A reactive center loop–based prediction platform to enhance the design of therapeutic SERPINs

Proceedings of the National Academy of Sciences
2021-11-09 | Journal article
Contributors: Wariya Sanrattana; Thibaud Sefiane; Simone Smits; Nadine D. van Kleef; Marcel H. Fens; Peter J. Lenting; Coen Maas; Steven de Maat
Source: check_circle
Crossref

Targeted SERPIN (TaSER): a dual-action antithrombotic agent that targets platelets for SERPIN delivery.

Journal of thrombosis and haemostasis : JTH
2021-10 | Journal article
Contributors: Sanrattana W; Smits S; Barendrecht AD; van Kleef ND; El Otmani H; Zivkovic M; Roest M; Renné T; Clark CC; de Maat S et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress

Research and practice in thrombosis and haemostasis
2021-07 | Journal article
Contributors: Krishnaswamy S; Ageno W; Arabi Y; Barbui T; Cannegieter S; Carrier M; Cleuren A; Collins P; Panicot‐Dubois L; Freedman J et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema

Clinical Reviews in Allergy & Immunology
2021-06-06 | Journal article
Contributors: Steven de Maat; Kusumam Joseph; Coen Maas; Allen P. Kaplan
Source: check_circle
Crossref

Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation.

EBioMedicine
2021-05 | Journal article
Contributors: Englert H; Rangaswamy C; Deppermann C; Sperhake JP; Krisp C; Schreier D; Gordon E; Konrath S; Haddad M; Pula G et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.

Frontiers in medicine
2021-04 | Journal article
Contributors: Clark CC; Jukema BN; Barendrecht AD; Spanjaard JS; Jorritsma NKN; Smits S; de Maat S; Seinen CW; Verhoef S; Parr NMJ et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Therapeutic SERPINs: Improving on Nature.

Frontiers in cardiovascular medicine
2021-03 | Journal article
Contributors: Maas C; de Maat S
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Caging the dragon: Research approach to COVID‐19–related thrombosis

Research and Practice in Thrombosis and Haemostasis
2021-02 | Journal article
Contributors: Marieke J.H.A. Kruip; Suzanne C. Cannegieter; Hugo ten Cate; Eric C.M. van Gorp; Nicole P. Juffermans; Frederikus A. Klok; Coen Maas; Anton Vonk‐Noordegraaf
Source: check_circle
Crossref

Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19.

The Journal of infectious diseases
2021-02 | Journal article
Contributors: Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

An increase in CD62L<sup>dim</sup> neutrophils precedes the development of pulmonary embolisms in COVID-19 patients.

Scandinavian journal of immunology
2021-01 | Journal article
Contributors: Spijkerman R; Jorritsma NKN; Bongers SH; Bindels BJJ; Jukema BN; Hesselink L; Hietbrink F; Leenen LPH; van Goor HMR; Vrisekoop N et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Defective NETs Clearance contributes to sustained FXII Activation in COVID-19-associated Pulmonary Thrombo-Inflammation

2020-12 | Preprint
OTHER-ID:

PPR259205

Contributors: Englert H; Rangaswamy C; Deppermann C; Sperhake J; Krisp C; Schreier D; Gordon E; Konrath S; Haddad M; Pula G et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Neutrophil fluorescence in clozapine users is attributable to a 14kDa secretable protein.

Pharmacology research & perspectives
2020-10 | Journal article
Contributors: de With SAJ; Man WH; Maas C; Ten Berg M; Cahn W; Koekman AC; van Solinge WW; Tak T
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate.

Blood
2020-09 | Journal article
Contributors: Mailer RK; Allende M; Heestermans M; Schweizer M; Deppermann C; Frye M; Pula G; Odeberg J; Gelderblom MP; Rose-John S et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy.

HemaSphere
2020-08 | Journal article
Contributors: Kusadasi N; Sikma M; Huisman A; Westerink J; Maas C; Schutgens R
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.

JAMA network open
2020-08 | Journal article
Contributors: van de Veerdonk FL; Kouijzer IJE; de Nooijer AH; van der Hoeven HG; Maas C; Netea MG; Brüggemann RJM
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE‐PLG patients

Allergy
2020-08 | Journal article
Contributors: Faidra Parsopoulou; Delphine Charignon; Maud Tengo; Fotis Psarros; Coen Maas; Teresa Gonzalez‐Quevedo; Christian Drouet; Anastasios E. Germenis; Arije Ghannam
Source: check_circle
Crossref

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.

Blood advances
2020-07 | Journal article
Contributors: Jansen AJG; Spaan T; Low HZ; Di Iorio D; van den Brand J; Tieke M; Barendrecht A; Rohn K; van Amerongen G; Stittelaar K et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.

Seminars in thrombosis and hemostasis
2020-06 | Journal article
Contributors: de Maat S; de Mast Q; Danser AHJ; van de Veerdonk FL; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

A systems approach to inflammation identifies therapeutic targets in SARS-CoV-2 infection

2020-05 | Other
OTHER-ID:

PPR166844

Contributors: van de Veerdonk FL; Janssen NA; Grondman I; de Nooijer AH; Koeken VA; Matzaraki V; Boahen CK; Kumar V; Kox M; Koenen HJ et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.

Frontiers in immunology
2020-05 | Journal article
Contributors: Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study.

The Journal of allergy and clinical immunology
2020-04 | Journal article
Contributors: Hofman ZLM; Clark CC; Hack CE; de Maat S; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE-PLG patients.

Allergy
2020-03 | Journal article
Contributors: Parsopoulou F; Charignon D; Tengo M; Psarros F; Maas C; Gonzalez-Quevedo T; Drouet C; Germenis AE; Ghannam A
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Cold-induced urticarial autoinflammatory syndrome related to factor XII activation.

Nature communications
2020-01 | Journal article
Contributors: Scheffel J; Mahnke NA; Hofman ZLM; Maat S; Wu J; Bonnekoh H; Pengelly RJ; Ennis S; Holloway JW; Kirchner M et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Evidence for bradykinin release in chronic spontaneous urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2020-01 | Journal article
Contributors: Hofman ZLM; van den Elzen MT; Kuijpers J; de Maat S; Hack CE; Knulst AC; Röckmann H; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence.

Thrombosis and haemostasis
2020-01 | Journal article
Contributors: Clark CC; Hofman ZLM; Sanrattana W; den Braven L; de Maat S; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood.

Scientific reports
2019-12 | Journal article
Contributors: de Vries JC; Barendrecht AD; Clark CC; Urbanus RT; Boross P; de Maat S; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Nomenclature of factor XI and the contact system

Journal of Thrombosis and Haemostasis
2019-12 | Journal article
Contributors: Alvin H. Schmaier; Jonas Emsley; Edward P. Feener; David Gailani; José W.P. Govers‐Riemslag; Allen P. Kaplan; Coen Maas; James H. Morrissey; Thomas Renné; Johannes J. Sidelmann et al.
Source: check_circle
Crossref

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood

Scientific Reports
2019-12-04 | Journal article
Contributors: Joost C. de Vries; Arjan D. Barendrecht; Chantal C. Clark; Rolf T. Urbanus; Peter Boross; Steven de Maat; Coen Maas
Source: check_circle
Crossref

A mutation in the kringle domain of human Factor XII that causes autoinflammation, disturbs zymogen quiescence and accelerates activation.

The Journal of biological chemistry
2019-11 | Journal article
Contributors: Hofman ZLM; Clark CC; Sanrattana W; Nosairi A; Parr N; Živkovic M; Krause K; Mahnke NA; Scheffel J; Hack CE et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.

Blood
2019-11 | Journal article
Contributors: de Maat S; Sanrattana W; Mailer RK; Parr NMJ; Hessing M; Koetsier RM; Meijers JCM; Pasterkamp G; Renné T; Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

Blood
2019-11-07 | Journal article
Contributors: Steven de Maat; Wariya Sanrattana; Reiner K. Mailer; Naomi M. J. Parr; Martin Hessing; Robert M. Koetsier; Joost C. M. Meijers; Gerard Pasterkamp; Thomas Renné; Coen Maas
Source: check_circle
Crossref

Nomenclature of factor XI and the contact system.

Journal of thrombosis and haemostasis : JTH
2019-08 | Journal article
Contributors: Schmaier AH; Emsley J; Feener EP; Gailani D; Govers-Riemslag JWP; Kaplan AP; Maas C; Morrissey JH; Renné T; Sidelmann JJ et al.
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Plasminflammation-An Emerging Pathway to Bradykinin Production.

Frontiers in Immunology
2019-08 | Journal article
Contributors: Maas C
Source: Self-asserted source
Coen Maas via Europe PubMed Central

Illustrated State-of-the-Art Capsules of the ISTH 2019 Congress in Melbourne, Australia.

Research and practice in thrombosis and haemostasis
2019-07 | Journal article
Contributors: Ward CM; Andrews RK
Source: Self-asserted source
Coen Maas via Europe PubMed Central

High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema.

Clinical and Translational Allergy
2019-07-12 | Journal article
Source: Self-asserted source
Coen Maas
grade
Preferred source (of 2)‎

Hereditary Angioedema: Insights into inflammation and allergy.

Molecular immunology
2019-07-04 | Journal article
Source: Self-asserted source
Coen Maas
Items per page:
Page 1 of 3

Peer review (4 reviews for 3 publications/grants)

Review activity for ACS chemical biology. (2)
Review activity for Journal of clinical immunology. (1)
Review activity for Thrombosis journal (1)